Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Triethylene Glycol SCHEMBL29103842 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL24748 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL607716 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL16437096 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL599527 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL607698 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL12865302 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL3552086 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL16437099 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 | |
| SCHEMBL606328 | 1.00 | TSHR (0.58) | TSHRNAAAKDM4EPOLBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022251588-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE | HALDA THERAPEUTICS OPCO, INC. (US) | 2022-12-01 | — | — | WO | disclosed |
| US-11173212-B2 | Supramolecular protein assemblies with advanced functions and synthesis thereof | INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IN) | 2021-11-16 | — | — | US | disclosed |
| US-11173212-B2 | Supramolecular protein assemblies with advanced functions and synthesis thereof | INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IN) | 2021-11-16 | — | — | US | disclosed |
| EP-3052465-B1 | POLYFUNCTIONALIZED POLYETHYLENE AND POLYPROPYLENE GLYCOL USEFUL AS TRACERS | RESMAN AS (NO) | 2020-07-29 | — | — | EP | disclosed |
| US-10364217-B2 | Chemical compounds | RESMAN AS (NO) | 2019-07-30 | — | — | US | disclosed |
| EP-1594440-B1 | THE SELECTIVE AND SPECIFIC PREPARATION OF DISCRETE PEG COMPOUNDS | QUANTA BIODESIGN LTD (US) | 2019-07-03 | — | — | EP | disclosed |
| US-20190134212-A1 | SUPRAMOLECULAR PROTEIN ASSEMBLIES WITH ADVANCED FUNCTIONS AND SYNTHESIS THEREOF | INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IN) | 2019-05-09 | — | — | US | disclosed |
| US-20190134212-A1 | SUPRAMOLECULAR PROTEIN ASSEMBLIES WITH ADVANCED FUNCTIONS AND SYNTHESIS THEREOF | INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH (IN) | 2019-05-09 | — | — | US | disclosed |
| EP-1613343-B1 | INSULIN POLYPEPTIDE-OLIGOMER CONJUGATES, PROINSULIN POLYPEPTIDE-OLIGOMER CONJUGATES AND METHODS OF SYNTHESIZING SAME | BIOCON LTD (IN) | 2016-12-07 | — | — | EP | disclosed |
| EP-3052465-A1 | CHEMICAL COMPOUNDS | Resman AS (NO) | 2016-08-10 | — | — | EP | disclosed |
| US-20030060606-A1 | Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same | BIOCON LIMITED (IN) | 2003-03-27 | — | — | US | disclosed |
| WO-2003022210-A2 | PHARMACEUTICAL COMPOSITIONS OF DRUG-OLIGOMER CONJUGATES AND METHODS OF TREATING DISEASES THEREWITH | NOBEX CORPORATION (US) | 2003-03-20 | — | — | WO | disclosed |
| WO-2003022996-A2 | METHODS OF SYNTHESIZING INSULIN POLYPEPTIDE-OLIGOMER CONJUGATES, AND PROINSULIN POLYPEPTIDE-OLIGOMER CONJUGATES AND METHODS OF SYNTHESIZING SAME | NOBEX CORPORATION (US) | 2003-03-20 | — | — | WO | disclosed |
| WO-2003022208-A2 | PHARMACEUTICAL COMPOSITIONS OF INSULIN DRUG-OLIGOMER CONJUGATES AND METHODS OF TREATING DISEASES THEREWITH | NOBEX CORPORATION (US) | 2003-03-20 | — | — | WO | disclosed |
| US-20030027748-A1 | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same | BIOCON LIMITED (IN) | 2003-02-06 | — | — | US | disclosed |
| US-20030027995-A1 | Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same | BIOCON LIMITED (IN) | 2003-02-06 | — | — | US | disclosed |
| WO-2002098452-A1 | MIXTURES OF GROWTH HORMONE DRUG-OLIGOMER CONJUGATES COMPROMISING POLYALKYLENE GLYCOL, USES THEREOF, AND METHODS OF MAKING SAME | NOBEX CORPORATION (US) | 2002-12-12 | — | — | WO | disclosed |
| WO-2002098446-A1 | MIXTURES OF DRUG-OLIGOMER CONJUGATES COMPRISING POLYALKYLENE GLYCOL, USES THEREOF, AND METHODS OF MAKING SAME | NOBEX CORPORATION (US) | 2002-12-12 | — | — | WO | disclosed |
| WO-2002098451-A1 | MIXTURES OF CALCITONIN DRUG-OLIGOMER CONJUGATES COMPRISING POLYALKYLENE GLYCOL, USES THEREOF, AND METHODS OF MAKING SAME | NOBEX CORPORATION (US) | 2002-12-12 | — | — | WO | disclosed |
| WO-2002098232-A1 | MIXTURES OF INSULIN DRUG-OLIGOMER CONJUGATES COMPRISING POLYALKYLENE GLYCOL, USES THEREOF, AND METHODS OF MAKING SAME | NOBEX CORPORATION (US) | 2002-12-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190134212-A1 | SUPRAMOLECULAR PROTEIN ASSEMBLIES WITH ADVANCED FUNCTIONS AND SYNTHESIS THEREOF | APC, CHLSN, MAX | TSHR 3255/4885NAAA 3208/4885KDM4E 4228/4885 |
| US-20030027748-A1 | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same | IAPP, SI, IDE | TSHR 1412/4885NAAA 1342/4885KDM4E 4615/4885 |
| US-20030027995-A1 | Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same | GHRHR, GHSR, GHITM | TSHR 43/4885NAAA 1229/4885KDM4E 4494/4885 |
| US-10364217-B2 | Chemical compounds | PTGES, PTGIS, PTGFR | TSHR 3608/4885NAAA 2263/4885KDM4E 4601/4885 |
| US-11173212-B2 | Supramolecular protein assemblies with advanced functions and synthesis thereof | APC, CHLSN, MAX | TSHR 3255/4885NAAA 3208/4885KDM4E 4228/4885 |
| US-20030060606-A1 | Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same | CALCB, CALCR, CALCA | TSHR 1403/4885NAAA 833/4885KDM4E 4598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.